Future use of the Glasgow alcoholic hepatitis score

Comment

I N Guha et al. Gut. 2006 Jan.

. 2006 Jan;55(1):135-6.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.
Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Forrest EH, et al. Gut. 2005 Aug;54(8):1174-9. doi: 10.1136/gut.2004.050781. Gut. 2005. PMID: 16009691 Free PMC article.

1. Carithers R L, Jr, Herlong H F, Diehl A M.et al Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989110685–690. - PubMed
1. Mathurin P, Mendenhall C L, Carithers R L., Jret al Corticosteroids improve short‐term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 200236480–487. - PubMed
1. Ramond M J, Poynard T, Rueff B.et al A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992326507–512. - PubMed
1. Mendenhall C L, Anderson S, Garcia‐Pont P.et al Short‐term and long‐term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 19843111464–1470. - PubMed
1. Bircher J, Benhamou J, Mcintyre N. (editors) Oxford Textbook of Clinical Hepatology, volume 2, 2nd Edn. New York: Oxford University Press, 19991185–1238.